You must have JavaScript enabled to view certain links and/or sign up for the Succeed Newsletter.
Grants.Gov

   Home  > Find Grant Opportunities > Search Grant Opportunities > Search Results > Synopsis

FY09 DOD Lung Cancer Clinical Fellow Research Award

Department of Defense

 
Synopsis
       


The synopsis for this grant opportunity is detailed below, following this paragraph. This synopsis contains all of the updates to this document that have been posted as of 08/03/2009 . If updates have been made to the opportunity synopsis, update information is provided below the synopsis.

If you would like to receive notifications of changes to the grant opportunity click send me change notification emails . The only thing you need to provide for this service is your email address. No other information is requested.

Any inconsistency between the original printed document and the disk or electronic document shall be resolved by giving precedence to the printed document.

Description of Modification

The purpose of this modification is to revise: (1) the Program Announcement document, (2) the Application Instructions & General Information document, and (3) the Application Form Package. The revised Application Form Package included in this modification must be used in completing the application. Failure to use this Application Form Package may result in the rejection of the application when submitted in Grants.gov.

Document Type: Modification to Previous  Grants Notice
Funding Opportunity Number: W81XWH-09-LCRP-CFRA
Opportunity Category: Discretionary
Posted Date: Aug 03, 2009
Creation Date: Aug 28, 2009
Original Closing Date for Applications: Dec 03, 2009   
Current Closing Date for Applications: Dec 03, 2009   
Archive Date: Jan 02, 2010
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 3
Estimated Total Program Funding: $650,000
Award Ceiling:
Award Floor:
CFDA Number(s): 12.420  --  Military Medical Research and Development
Cost Sharing or Matching Requirement: No

Eligible Applicants

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
 

Additional Information on Eligibility:


Agency Name

Dept. of the Army -- USAMRAA

Description

The LCRP Clinical Fellow Research Award (CFRA) supports a research project performed by a clinical fellow under the guidance of a designated mentor having an established lung cancer research program. This award is intended to prepare fellows with clinical duties and/or responsibilities for a career in lung cancer research. The Principal Investigator (PI) must be in either an accredited medical residency or medical fellowship program. The DOD LCRP strongly encourages submissions from, and partnerships with, investigators at Military Treatment Facilities, Military Research Institutions, and the Department of Veterans Affairs (VA) Medical Centers and research laboratories.Funds from this award are intended to provide aggressive protection, of at least 40%, of the clinical fellow’s time for research. The clinical fellow must demonstrate a strong commitment to a career in lung cancer research and clinical practice.Areas of Emphasis: The FY09 LCRP CFRA ONLY accepts applications that address at least one of the seven Areas of Emphasis listed below:• Identification or development of non-invasive or minimally invasive tools to improve the detection of the initial stages of lung cancer• Identification and development of tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging, biomarkers, genetics/genomics/proteomics, and assessment of risk factors• Understanding the molecular mechanisms that lead to clinically significant lung cancer• Identification of the mechanisms that lead to the development of the various types of lung cancer• Identification of innovative strategies for prevention and treatment of early lung cancer• Understanding predictive and prognostic markers to identify responders and non-responders• Understanding acquired resistance to treatmentSee the Program Announcement for the full Funding Opportunity Description.

Link to Full Announcement

If you have difficulty accessing the full announcement electronically, please contact:

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Helpdesk

Synopsis Modification History

The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.

File Name Date
Modification #1 Aug 28, 2009
Original Synopsis Aug 03, 2009